Do Elderly Patients With Stage I–II Hepatocellular Carcinoma Benefit From More Radical Surgeries? A Population-Based Analysis

Background and Aims: The best treatment modalities for elderly patients with stage I–II HCC (hepatocellular carcinoma) remain controversial in an era of a shortage of liver donors. Methods: From the SEER database (Surveillance, Epidemiology, and End Results program), 2,371 elderly patients were samp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiu-Qiang, Wu, Pan-Yi-Sha, ALBahde, Mugahed, Zhang, Lu-Fei, Zhou, Zhu-Ha, Liu, Hua, Li, Yu-Feng, Wang, Wei-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176977/
https://www.ncbi.nlm.nih.gov/pubmed/32373517
http://dx.doi.org/10.3389/fonc.2020.00479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176977/
https://www.ncbi.nlm.nih.gov/pubmed/32373517
http://dx.doi.org/10.3389/fonc.2020.00479

Ejemplares similares